Thu, Mar 5, 2015, 11:32 AM EST - U.S. Markets close in 4 hrs 28 mins

Recent

% | $
Quotes you view appear here for quick access.

Fidelity National Financial, Inc. Message Board

rrtzrealmd 1771 posts  |  Last Activity: Mar 3, 2015 4:21 PM Member since: Aug 24, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • rrtzrealmd rrtzrealmd Mar 3, 2015 4:21 PM Flag

    Uhhhhhhh...excuse me? What are you talking about? I said:

    "Seriously? So Silicon Bank DEMANDED that the new CFO unload some of her shares for...uhhhhhhhhh...what reason -- exactly? If you're going to fantasize, at least TRY to stay within the sphere of reality."

    That was after YOU said:

    "SEC D-Filing Was NOT A Big Deal. It Was Associated With Silicon Bank Agreement"

    ...which is simply nonsense! Why would the bank demand Rosa, Drayton, Olesen, Watson, and the others to sell $600,000 worth of shares? A simpler explanation is that the hogs were getting hungary and demanding someone fill up the trough! Don't want Warren Watson and those new "superstars" getting hungary now, do we?

  • Reply to

    SSH stands for sinking ship

    by stocktradingguy1974 Mar 3, 2015 10:51 AM
    rrtzrealmd rrtzrealmd Mar 3, 2015 11:13 AM Flag

    ...aren't fleeing? Shoot no! They'll stay and shake down every sucker they can find for every dime they can! Biotechs ALWAYS have the best troughs to feed at! And empty promises are guaranteed to keep that trough filled for as long as stockbrokers are willing to sell the stock!

  • Reply to

    it leaked dout to the insiders

    by gerbduge Mar 3, 2015 9:43 AM
    rrtzrealmd rrtzrealmd Mar 3, 2015 11:07 AM Flag

    ...welllllllll...don't know if there's "bad news," but wasn't it quite the COINCIDENCE that the fluff PR about the "interim analysis" came out ALONG with a "paid pumper" recommendation from One Equity Research JUST AS the secondary offering was filed with the SEC! Geez! Have they NO shame?

  • rrtzrealmd rrtzrealmd Mar 3, 2015 11:01 AM Flag

    Seriously? So Silicon Bank DEMANDED that the new CFO unload some of her shares for...uhhhhhhhhh...what reason -- exactly? If you're going to fantasize, at least TRY to stay within the sphere of reality.

  • rrtzrealmd rrtzrealmd Mar 3, 2015 3:08 AM Flag

    "Imagine the anxiety and sweat these people..."??? Yeah, Dave really busted a gut to collect his well over MILLION dollar sslary, benefits, bonuses, and perks in 2013! And now shareholders get to reap the "benefits" of all his effort! Over a YEAR and a HALF into the trial before the MORON realizes that insurance companies weren't going to fund the trial for him! I can just "imagine the sweat and anxiety" of anyone who bought a year ago at11-12 dollars a share and are now watching the company flop around like a fish out of water while they sit back and calculate their 40-50% LOSSES!

  • rrtzrealmd rrtzrealmd Mar 3, 2015 3:02 AM Flag

    And you're surprised? Can't imagine why! The fluff PR about the interim analysis which told you NOTHING about the endpoints of the analysis or how it was going to be monitored followed by a secondary offering -- seems pretty par for the biotech course to me.

    I thought it was rather funny that they checked the "Decline to Disclose" box under company revenues! Guess they haven't been selling too many c-pulses over in Europe, huh?

    And evidently Ms. Drayton, the new CFO, thought she better get on the gravy train quick before Dave runs it off the rails. Didn't take her long to her nose into the shareholder equity trough, did it?

  • Reply to

    Clinical Trial Question - SSH

    by super_rg1 Dec 31, 2014 10:12 AM
    rrtzrealmd rrtzrealmd Dec 31, 2014 11:04 AM Flag

    Per the clinicaltrials website, negative "events" include death, LVAD placemnt, heart transplant, and hospitalization. Consider that the feasibility trial had -- by those criteria -- greater than 50% NEGATIVE events. Also consider that in the feasibility trial, the RATE of LVAD/heart transplants was something like 200-300 TIMES that usually seen in the class III CHF population in general. Not exactly numbers to make one optimistic about the chances of trial success.

  • Reply to

    Clinical Trial Question - SSH

    by super_rg1 Dec 31, 2014 10:12 AM
    rrtzrealmd rrtzrealmd Dec 31, 2014 10:57 AM Flag

    "This is an events based trial. At 265 events, the trial ends."??? That's debatable. The clinicaltrials website does NOT describe it as events based. It clearly specifies a 12 month time frame for tracking data post-implant.

    SSH, in ONE presentation that I could find, MENTIONED 265 events but did NOT clarify exactly what would HAPPEN at 265 events. Rosa ALLEGED in an interview that if c-pulse showed a 30% improvement versus OMT after 265 events, then it would be approved. HOWEVER, nowhere can I find SSH spelling out EXACTLY how the trial is to be decided.

    Now, I have NEVER heard of an FDA trial decision being based on a specific percentage of events. Indeed, I have never heard of the FDA making a decision about a trial based on a specific number of events. EVERY trial I have EVER read -- and I've read a LOT -- required a specific number of patients in control and experimental groups that would be studied over a specified time with the data collected and then statistically analyzed for significant differences. Given the general level of incompetence that I have witnessed so far in SSH management, I have to wonder whether SSH's 265 event claim is reliable.

  • Reply to

    Clinical Trial Question - SSH

    by super_rg1 Dec 31, 2014 10:12 AM
    rrtzrealmd rrtzrealmd Dec 31, 2014 10:36 AM Flag

    Absolutely correct! However, there is one leeeeeetle problem! You see, the dimwit management apparently was COUNTING ON insurance companies to pay for all the follow-up and post-implant care of the subjects! Had ANYONE bothered to read ANY of the insurance medical policy manuals they would have seen that insurance NEVER covers experimental devices.

    Now the research hospitals finance departments are REFUSING to allow implants without some guarantee of reimbursement of the expected "200,000...250,000...uncapped" costs associated with each device. Insurance companies have said they WON'T! And Rosa announced at the last conference call that SSH could NOT and be successful. He said that some of the hospitals would simply have to be replaced and that SSH was TRYING to negotiate deals with the others. HOWEVER, there has been no furhter update as to how successful they've been. Rosa warned not to be too optimistic about the number of implants expected this quarter -- in other words, don't expect ANY!

    So far, there are only THREE verifiable implants that have been done in the over YEAR and a HALF since the trial started. So to reach 198 you're looking at maybe another 60...70...80 or more YEARS! SSH ALLEGED that they were seeking an early review from the FDA and EXPECTED to hear something before the end of the year. Obviously, nothing has appeared so far -- probably too busy trying to figure out how to fund the "pivotal" trial!

  • ...its way to ZERO where it belongs? About time! One of the most embarrassingly stupid companies I've ever seen and I've seen a slew! It even looks like the ORMP seekingalpha pump queen "di Stefano" has given up trying to promote this scam! Now THAT shows you how bad it is!

  • Reply to

    Nice Comments

    by evlradr Dec 13, 2014 8:09 AM
    rrtzrealmd rrtzrealmd Dec 13, 2014 10:35 PM Flag

    You might want to consider that Donnenfeld is part of the trio of "Lindstrom, Kim, and Donnenfeld" who are most likely all gOMER "paid consultants" -- guys who would probably hump their own grandmother for a buck. Also consider that Donnenfeld is also on the board of "Novabay Paharmaceuticals" -- currently trading at 69 CENTS -- and he probably contributes no more to that company than a phone call every quarter to collect his director's fee.

  • Reply to

    Omidria

    by whatamimissing1 Dec 4, 2014 1:42 PM
    rrtzrealmd rrtzrealmd Dec 13, 2014 10:15 PM Flag

    Omridia -- IF ordered -- will be mixed by the hospital pharmacist and delivered to the eye doc in the surgery suite. I say "if" because "The Wholesale Acquisition Cost (WAC) for OMIDRIA is $465 per single-use vial," and I believe that any self-respecting eye doc will find it patently absurd to force the health care system to pay $465 for 25 CENTS worth of generic drugs -- ESPECIALLY when you consider that eye surgery has been doing perfectly well WITHOUT it.

  • rrtzrealmd rrtzrealmd Dec 11, 2014 4:22 PM Flag

    ...you have to forgive him...SSH hit a NEW 52 week LOW today and that has exacerbated his already serious case of "bagholderitis" -- a disease which tends to leave its victims rather discombobulated.

  • rrtzrealmd rrtzrealmd Dec 8, 2014 12:12 PM Flag

    Wow! Three posts in less than ten minutes! Sounds like an acute exacerbation of "bagholderitis"! Too bad there's no "cure"!

  • rrtzrealmd rrtzrealmd Dec 6, 2014 11:43 AM Flag

    ...uhhhh -- cuz no one is willing to pay for it? At least that's what the CEO said in the conference call. Insurance companies refuse to reimburse; finance departments of research hospitals refuse to implant without GUARANTEE of reimbursement; CEO said SSH can't guarantee reimbursement because it couldn't succeed if it has to pay "200,000...250,000, uncapped costs" that are associated with managing each patient through the study. He also said Medicare can't help since the average age of the patients in the trial is somewhere south of 65!

    Are you familiar with the old saying about "up a sh_t creek without a paddle"?

  • rrtzrealmd rrtzrealmd Dec 4, 2014 11:33 AM Flag

    ...hmmmmm...one could argue that "HF patients, PI and Staff at sites are not interested in" c-pulse either judging from the THREE verifiable implants in the YEAR and a HALF the trial has been running.

    Certainly, insurance companies aren't interested in it -- as demonstrated by their REFUSING to reimburse the device! The question now is HOW will the trial be funded. The research hospitals want guarantees of reimbursement which Rosa says SSH can't afford! No money means no implants means no data to show the FDA . In other words, SSH is effectively a "beached whale" at this point -- and you know what happens ultimately to beached whales, don't you?

  • Reply to

    Evidence for Bearcrusher alias rrtzrealmed

    by aus_xc Dec 3, 2014 4:30 PM
    rrtzrealmd rrtzrealmd Dec 4, 2014 11:26 AM Flag

    See my response above.

  • Reply to

    Evidence for Bearcrusher alias rrtzrealmed

    by aus_xc Dec 3, 2014 4:30 PM
    rrtzrealmd rrtzrealmd Dec 4, 2014 11:25 AM Flag

    Begging your pardon, but I actually DID address the "33% improvement" in my own special way:

    Funny, isn't it, that after those first 5 or 6 patients from Germany there HASN'T been ANOTHER? ZERO from Germany LAST quarter! ZERO from Germany THIS quarter!! When WAS the last patient implanted in Germany?

    On top of that, not ONE stinkin' c-pulse SOLD in Germany DESPITE EU approval TWO YEARS ago and DESPITE German NUB reimbursement approval a YEAR ago!

    Fat lot of good Dr. Hotz's EF success did -- wouldn't you agree?"

    Since, apparently, NO ONE in Germany CARES about Hotz's "33% improvement," why should I?

    However, if you WANT more, then consider that Aggarwal and Kao reported that TWO THIRDS of THEIR six patient showed NO significant improvement in EF after c-pulse. What's that all about? Does Hotz get better "consulting fees"?

    Also consider how ODD it is that, despite Dr. Hotz's "success," SSH does NOT include EF in EITHER the "pivotal" US trial OR in the European trial! I would think an OBJECTIVE measure like that would impress cardiologists and maybe attract more referrals.

    Of course, given the current insurance refusal to reimburse DEBACLE, I suppose referrals no longer matter much!

  • rrtzrealmd rrtzrealmd Dec 3, 2014 10:04 PM Flag

    "...talk with investor relations'??? Wouldn't that be kinda like asking Jeffrey Dahmer for vegetarian recipes?

  • Reply to

    Evidence for Bearcrusher alias rrtzrealmed

    by aus_xc Dec 3, 2014 4:30 PM
    rrtzrealmd rrtzrealmd Dec 3, 2014 10:02 PM Flag

    Hotz??? Oh, you're referring to Dr. Hotz from Germany! The guy who is a "paid consultant" for SSH and who gets ALL of his travel expenses PAID FOR by SSH?

    Yeah! Funny, isn't it, that after those first 5 or 6 patients from Germany there HASN'T been ANOTHER? ZERO from Germany LAST quarter! ZERO from Germany THIS quarter!! When WAS the last patient implanted in Germany?

    On top of that, not ONE stinkin' c-pulse SOLD in Germany DESPITE EU approval TWO YEARS ago and DESPITE German NUB reimbursement approval a YEAR ago!

    Fat lot of good Dr. Hotz's EF success did -- wouldn't you agree?

    Haven't heard from him much lately -- was he the "personnel" change in Europe SSH tried to blame for NO European implants in the quarterly report? Yeah, cutting off his cash flow tends to quiet down a doc.

FNF
35.8807+0.1907(+0.53%)11:32 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.